Micro Labs Limited has announced the appointment of Balaji Borlepwar as Executive Vice President – India GX & Wellness Divisions, a move aimed at accelerating strategic growth across its generics and wellness portfolios. In his new role, Balaji will lead efforts to strengthen market leadership, broaden access, and drive patient-centric innovations, all aligned with Micro Labs’ long-term vision of expanding affordable healthcare solutions.
Bringing with him nearly 30 years of experience in the pharmaceutical industry, Balaji has held senior leadership roles at prominent companies like Cipla and Lupin. During his tenure at Cipla Gx, he played a pivotal role in cementing the company’s position as India’s No. 1 generics player, driving strong growth and expanding the company’s reach across various regions. His track record includes scaling branded generics and leading high-impact market expansion initiatives.
Balaji is known for his sharp execution skills and people-first leadership style, making him a highly respected figure in the industry. His expertise spans key functions such as sales, marketing, and strategic planning, equipping him with the tools to deliver sustainable business outcomes.
An MBA in Marketing from the Symbiosis Institute of Business Management, Balaji is widely recognized for blending commercial acumen with operational discipline. His leadership is expected to be crucial as Micro Labs intensifies its focus on innovation and accessibility in both generics and wellness segments.
Commenting on his new role, Balaji said, “I’m excited to join Micro Labs at a pivotal time in its journey. The opportunity to contribute to the company’s mission of delivering high-quality, affordable healthcare to patients across India is truly meaningful.”
His appointment reinforces Micro Labs’ commitment to building a future-ready organization that prioritizes access, innovation, and excellence. As EVP, Balaji will spearhead strategies aimed at enhancing the company’s impact in the Indian healthcare landscape, while fostering growth through robust, sustainable practices.
